Literature DB >> 32782147

Chondrogenic differentiation followed IGFBP3 loss in human endometrial mesenchymal stem cells.

Roman E Ushakov1, Elena V Skvortsova2, Mikhail A Vitte3, Irina O Vassilieva4, Alla N Shatrova5, Anastasiya V Kotova6, Vladimir M Kenis7, Elena B Burova8.   

Abstract

Insulin-like growth factor binding protein 3 (IGFBP3) is a multifunctional protein, able either to stimulate the cell growth or to promote apoptosis. In particular, IGFBP3 plays significant role in propagation of stress-induced senescence in human endometrium-derived mesenchymal stem cells (MESCs) (Vassilieva et al., 2020). We undertook CRISPR/Cas9-mediated IGFBP3 knockout in an effort to decelerate stress-induced senescence in MESCs, but, unexpectedly, IGFBP3-knockout MESCs culture acquired chondrocyte-like features, such as cell condensation and aggregation. We revealed that IGFBP3-knockout MESCs completely lost CD73 and CD90 MESCs positive surface markers, and significantly decreased expression of CD105 and CD146 MESCs positive surface markers. In addition, we found IGFBP3-knockout MESCs aggregates positively stained for Alcian Blue. We also detected expression of collagen type II in IGFBP3-knockout MESCs. The obtained results indicate that MESCs lost stemness after IGFBP3-knockout and underwent differentiation toward chondrogenic lineage. Our findings can enlighten IGFBP3 role in regulation of MESCs chondrogenesis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chondrogenesis; Differentiation; Gene knockout; IGFBP3; Mesenchymal stem cells; Multipotency

Year:  2020        PMID: 32782147     DOI: 10.1016/j.bbrc.2020.07.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Non-gynaecological Applications of Menstrual-derived Stem Cells: A Systematic Review.

Authors:  Claire Galea; Nicoletta Riva; Jean Calleja-Agius
Journal:  Avicenna J Med Biotechnol       Date:  2022 Jan-Mar

Review 2.  Emerging strategies in reprogramming and enhancing the fate of mesenchymal stem cells for bone and cartilage tissue engineering.

Authors:  Yu Seon Kim; Antonios G Mikos
Journal:  J Control Release       Date:  2020-12-31       Impact factor: 9.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.